Ongoing trials in Alzheimer’s disease

By Sramek J.J.   Cutler N.R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 899-915

Informa Healthcare

Access to resources Recommend Favorite

Antioxidant Clinical Trials in Mild Cognitive Impairment and Alzheimer’s disease – Challenges and Perspectives

By  

Current Pharmaceutical Design, Vol. 20, Iss. 18, 2014-06 ,pp. : 3083-3092

Bentham Science Publishers

Access to resources Recommend Favorite

Conference Report: 10th Clinical Trials on Alzheimer's Disease (CTAD), Boston MA, USA, November 1-4, 2017

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 10, 2018-03 ,pp. : 1134-1137

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological strategies for the prevention of Alzheimer’s disease

By Doraiswamy P Murali   Xiong Glen L  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 1, 2006-01 ,pp. : 1-10

Informa Healthcare

Access to resources Recommend Favorite

Emerging strategies for the treatment of Alzheimer’s disease at the Millennium

By Emmerling M.R.   Spiegel K.   D Hall E.   LeVine H.   Walker L.C.   Schwarz R.D.   Gracon S.  

Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. : 35-86

Informa Healthcare

Access to resources Recommend Favorite